ASCO GU 2023 Randomized Double-Blind Phase 3 KEYNOTE-921 Study: Pembro + Docetaxel for Patients With mCRPC
By
ASCO GU 2023 Conference Coverage
FEATURING
Daniel Petrylak
By
ASCO GU 2023 Conference Coverage
FEATURING
Daniel Petrylak
Login to view comments.
Click here to Login